{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:38:24Z","timestamp":1787009904599,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T00:00:00Z","timestamp":1744934400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1097\/bs9.0000000000000232","type":"journal-article","created":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T15:00:06Z","timestamp":1744988406000},"page":"e00232","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Novel NUP98:TNRC18 fusion transcript in acute myeloid leukemia: a case report and literature review"],"prefix":"10.1097","volume":"7","author":[{"given":"Lijuan","family":"Gao","sequence":"first","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghong","family":"Zhang","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Suzhou Jsuniwell Medical Laboratory, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changgeng","family":"Ruan","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suning","family":"Chen","sequence":"additional","affiliation":[{"name":"National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China"},{"name":"Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,18]]},"reference":[{"issue":"12","key":"R1-20250418","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.","volume":"140","author":"Dohner","year":"2022","journal-title":"Blood"},{"issue":"7","key":"R2-20250418","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: myeloid and histiocytic\/dendritic neoplasms.","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"R3-20250418","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data.","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"19","key":"R4-20250418","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1182\/bloodadvances.2024012960","article-title":"NUP98 is rearranged in 5.0% of adult East Asian patients with AML.","volume":"8","author":"Kim","year":"2024","journal-title":"Blood Adv"},{"issue":"2","key":"R5-20250418","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","article-title":"A new genomic framework to categorize pediatric acute myeloid leukemia.","volume":"56","author":"Umeda","year":"2024","journal-title":"Nat Genet"},{"issue":"1","key":"R6-20250418","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41408-024-01066-y","article-title":"The landscape of NUP98 rearrangements clinical characteristics and treatment response from 1491 acute leukemia patients.","volume":"14","author":"Tian","year":"2024","journal-title":"Blood Cancer J"},{"issue":"11","key":"R7-20250418","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1182\/bloodadvances.2023012479","article-title":"Identification of novel NUP98 fusion partners and comutations in acute myeloid leukemia: an adult cohort study.","volume":"8","author":"Heald","year":"2024","journal-title":"Blood Adv"},{"issue":"3","key":"R8-20250418","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/leu.2016.267","article-title":"NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis.","volume":"31","author":"Struski","year":"2017","journal-title":"Leukemia"},{"issue":"9","key":"R9-20250418","doi-asserted-by":"crossref","first-page":"e70013","DOI":"10.1002\/hem3.70013","article-title":"NUP98 oncofusions in myeloid malignancies: an update on molecular mechanisms and therapeutic opportunities.","volume":"8","author":"Rasouli","year":"2024","journal-title":"Hemasphere"},{"issue":"8","key":"R10-20250418","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1080\/10428194.2022.2047672","article-title":"Adult acute myeloid leukemia patients with NUP98 rearrangement have frequent cryptic translocations and unfavorable outcome.","volume":"63","author":"Xie","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"R11-20250418","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41594-020-00550-w","article-title":"Biomolecular condensation of NUP98 fusion proteins drives leukemogenic gene expression.","volume":"28","author":"Terlecki-Zaniewicz","year":"2021","journal-title":"Nat Struct Mol Biol"},{"issue":"24","key":"R12-20250418","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","article-title":"NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights.","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"issue":"4","key":"R13-20250418","doi-asserted-by":"crossref","first-page":"528","DOI":"10.3390\/cancers11040528","article-title":"The role of HOX transcription factors in cancer predisposition and progression.","volume":"11","author":"Li","year":"2019","journal-title":"Cancers (Basel)"},{"issue":"49","key":"R14-20250418","doi-asserted-by":"crossref","first-page":"e2211429119","DOI":"10.1073\/pnas.2211429119","article-title":"Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia.","volume":"119","author":"Cheng","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"R15-20250418","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/ejhg.2012.129","article-title":"RNA-Seq and human complex diseases: recent accomplishments and future perspectives.","volume":"21","author":"Costa","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"20","key":"R16-20250418","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood.2020007093","article-title":"Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.","volume":"136","author":"Michmerhuizen","year":"2020","journal-title":"Blood"},{"issue":"15","key":"R17-20250418","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1182\/blood-2014-04-570929","article-title":"NUP98\/NSD1 and FLT3\/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.","volume":"124","author":"Ostronoff","year":"2014","journal-title":"Blood"},{"issue":"7987","key":"R18-20250418","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41586-023-06688-z","article-title":"TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons.","volume":"623","author":"Zhao","year":"2023","journal-title":"Nature"},{"key":"R19-20250418","first-page":"100482","article-title":"Venetoclax for an ATRA and ATO resistance acute promyelocytic leukemia patient with TNRC18::RARA fusion gene.","volume":"22","author":"Li","year":"2024","journal-title":"Leuk Res Rep"},{"issue":"1","key":"R20-20250418","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41467-022-29336-y","article-title":"Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification.","volume":"13","author":"Liu","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"R21-20250418","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1182\/blood.2019003267","article-title":"CDK6 is an essential direct target of NUP98 fusion proteins in acute myeloid leukemia.","volume":"136","author":"Schmoellerl","year":"2020","journal-title":"Blood"},{"issue":"8","key":"R22-20250418","doi-asserted-by":"crossref","first-page":"e935","DOI":"10.1097\/HS9.0000000000000935","article-title":"The MLL-menin interaction is a therapeutic vulnerability in NUP98-rearranged AML.","volume":"7","author":"Rasouli","year":"2023","journal-title":"Hemasphere"}],"container-title":["Blood Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000232","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,18]],"date-time":"2025-04-18T15:00:09Z","timestamp":1744988409000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BS9.0000000000000232"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,18]]},"references-count":22,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/bs9.0000000000000232","relation":{},"ISSN":["2543-6368"],"issn-type":[{"value":"2543-6368","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,18]]}}}